Cargando…
Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys
BACKGROUND: The Global Programme to Eliminate Lymphatic Filariasis has encouraged countries to follow a set of guidelines to help them assess the need for mass drug administration and evaluate its progress. Papua New Guinea (PNG) is one of the highest priority countries in the Western Pacific for ly...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280391/ https://www.ncbi.nlm.nih.gov/pubmed/30533996 http://dx.doi.org/10.1186/s41182-018-0123-8 |
_version_ | 1783378660000006144 |
---|---|
author | Berg Soto, Alvaro Xu, Zhijing Wood, Peter Sanuku, Nelly Robinson, Leanne J. King, Christopher L. Tisch, Daniel Susapu, Melinda Graves, Patricia M. |
author_facet | Berg Soto, Alvaro Xu, Zhijing Wood, Peter Sanuku, Nelly Robinson, Leanne J. King, Christopher L. Tisch, Daniel Susapu, Melinda Graves, Patricia M. |
author_sort | Berg Soto, Alvaro |
collection | PubMed |
description | BACKGROUND: The Global Programme to Eliminate Lymphatic Filariasis has encouraged countries to follow a set of guidelines to help them assess the need for mass drug administration and evaluate its progress. Papua New Guinea (PNG) is one of the highest priority countries in the Western Pacific for lymphatic filariasis and the site of extensive research on lymphatic filariasis and surveys of its prevalence. However, different diagnostic tests have been used and thresholds for each test are unclear. METHODS: We reviewed the prevalence of lymphatic filariasis reported in 295 surveys conducted in PNG between 1990 and 2014, of which 65 used more than one test. Results from different diagnostics were standardised using a set of criteria that included a model to predict antigen prevalence from microfilariae prevalence. We mapped the point location of each of these surveys and categorised their standardised prevalence estimates. RESULTS: Several predictive models were produced and investigated, including the effect of any mass drug administration and number of rounds prior to the surveys. One model was chosen based on goodness of fit parameters and used to predict antigen prevalence for surveys that tested only for microfilariae. Standardised prevalence values show that 72% of all surveys reported a prevalence above 0.05. High prevalence was situated on the coastal north, south and island regions, while the central highland area of Papua New Guinea shows low levels of prevalence. CONCLUSIONS: Our study is the first to provide an explicit predictive relationship between the prevalence values based on empirical results from antigen and microfilaria tests, taking into account the occurrence of mass drug administration. This is a crucial step to combine studies to develop risk maps of lymphatic filariasis for programme planning and evaluation, as shown in the case of Papua New Guinea. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41182-018-0123-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6280391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62803912018-12-10 Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys Berg Soto, Alvaro Xu, Zhijing Wood, Peter Sanuku, Nelly Robinson, Leanne J. King, Christopher L. Tisch, Daniel Susapu, Melinda Graves, Patricia M. Trop Med Health Research BACKGROUND: The Global Programme to Eliminate Lymphatic Filariasis has encouraged countries to follow a set of guidelines to help them assess the need for mass drug administration and evaluate its progress. Papua New Guinea (PNG) is one of the highest priority countries in the Western Pacific for lymphatic filariasis and the site of extensive research on lymphatic filariasis and surveys of its prevalence. However, different diagnostic tests have been used and thresholds for each test are unclear. METHODS: We reviewed the prevalence of lymphatic filariasis reported in 295 surveys conducted in PNG between 1990 and 2014, of which 65 used more than one test. Results from different diagnostics were standardised using a set of criteria that included a model to predict antigen prevalence from microfilariae prevalence. We mapped the point location of each of these surveys and categorised their standardised prevalence estimates. RESULTS: Several predictive models were produced and investigated, including the effect of any mass drug administration and number of rounds prior to the surveys. One model was chosen based on goodness of fit parameters and used to predict antigen prevalence for surveys that tested only for microfilariae. Standardised prevalence values show that 72% of all surveys reported a prevalence above 0.05. High prevalence was situated on the coastal north, south and island regions, while the central highland area of Papua New Guinea shows low levels of prevalence. CONCLUSIONS: Our study is the first to provide an explicit predictive relationship between the prevalence values based on empirical results from antigen and microfilaria tests, taking into account the occurrence of mass drug administration. This is a crucial step to combine studies to develop risk maps of lymphatic filariasis for programme planning and evaluation, as shown in the case of Papua New Guinea. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41182-018-0123-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-04 /pmc/articles/PMC6280391/ /pubmed/30533996 http://dx.doi.org/10.1186/s41182-018-0123-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Berg Soto, Alvaro Xu, Zhijing Wood, Peter Sanuku, Nelly Robinson, Leanne J. King, Christopher L. Tisch, Daniel Susapu, Melinda Graves, Patricia M. Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
title | Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
title_full | Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
title_fullStr | Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
title_full_unstemmed | Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
title_short | Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
title_sort | combining different diagnostic studies of lymphatic filariasis for risk mapping in papua new guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280391/ https://www.ncbi.nlm.nih.gov/pubmed/30533996 http://dx.doi.org/10.1186/s41182-018-0123-8 |
work_keys_str_mv | AT bergsotoalvaro combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT xuzhijing combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT woodpeter combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT sanukunelly combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT robinsonleannej combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT kingchristopherl combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT tischdaniel combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT susapumelinda combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys AT gravespatriciam combiningdifferentdiagnosticstudiesoflymphaticfilariasisforriskmappinginpapuanewguineaapredictivemodelfrommicrofilaraemiaandantigenaemiaprevalencesurveys |